Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2nd February 2016 -5th May 2016
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay
Target gene:
Histidine requirement in Salmonela typhimurium Stains
Tryptophan requirement in Eschericha coli strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Test concentrations with justification for top dose:
Dose levels tested were 2.50, 7.50, 25.0, 75.0, 250 and 750 μg per plate with S9 activation and 0.250, 0.750, 2.50, 7.50, 25.0 and 75.0 μg per plate without S9 activation.

Justification: - The above doses were used based on the results obtained for the prelimary studies. Preliminary toxicity assay, the dose levels tested were 6.67, 10.0, 33.3, 66.7, 100, 333, 667, 1000, 3333 and 5000 μg per plate.P recipitate was observed beginning at 333 or 667 μg per plate. Toxicity was observed beginning at 33.3 to 667 μg per plate.
Vehicle / solvent:
Ethanol
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Details on test system and experimental conditions:
Overnight cultures were prepared by inoculating from the appropriate frozen permanent stock into a vessel, containing 30 to 50 mL of culture medium. To assure that cultures were harvested in late log phase, the length of incubation was controlled and monitored. Following inoculation, each flask was placed in a shaker/incubator programmed to begin shaking at 125 to 175 rpm and incubating at 37±2°C for approximately 12 hours before the anticipated time of harvest. Each culture was monitored spectrophotometrically for turbidity and was harvested at a percent transmittance yielding a titer of greater than or equal to 0.3x109 cells per milliliter. The actual titers were determined by viable count assays on nutrient agar plates. Each plate was identified by the BioReliance study number and a code system to designate the treatment condition, dose level and test phase, as described in detail in BioReliance's Standard Operating Procedures. Aroclor 1254-induced rat liver S9 was used as the metabolic activation system. The S9 was prepared from male Sprague-Dawley rats that were injected intraperitoneally with Aroclor™ 1254 (200 mg/mL in corn oil) at a dose of 500 mg/kg, five days before sacrifice. The S9 was stored at -60°C or colder until used. Each bulk preparation of S9 was assayed for its ability to metabolize benzo(a)pyrene and 2-aminoanthracene to forms mutagenic to Salmonella typhimurium TA100.
Evaluation criteria:
All Salmonella tester strain cultures must demonstrate the presence of the deep rough mutation (rfa) and the deletion in the uvrB gene. Cultures of tester strains TA98 and TA100 must demonstrate the presence of the pKM101 plasmid R-factor. All WP2 uvrA cultures must demonstrate the deletion in the uvrA gene.
All cultures must demonstrate the characteristic mean number of spontaneous revertants in the vehicle controls as follows (inclusive): TA98, 10 - 50; TA100, 80 - 240; TA1535, 5 - 45; TA1537, 3 - 21; WP2 uvrA, 10 - 60.

To ensure that appropriate numbers of bacteria are plated, tester strain culture titers must be greater than or equal to 0.3x109 cells/mL.
The mean of each positive control must exhibit at least a 3.0-fold increase in the number of revertants over the mean value of the respective vehicle control.
A minimum of three non-toxic dose levels is required to evaluate assay data. A dose level is considered toxic if one or both of the following criteria are met: A >50 % reduction in the mean number of revertants per plate as compared to the mean vehicle control value. This reduction must be accompanied by an abrupt dose-dependent drop in the revertant count. At least a moderate reduction in the background lawn.

For each replicate plating, the mean and standard deviation of the number of revertants per plate were calculated and are reported.
For the test article to be evaluated positive, it must cause a dose-related increase in the mean revertants per plate of at least one tester strain over a minimum of two increasing concentrations of test article as specified below:
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
ambiguous
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Remarks on result:
other:
Remarks:
2.0-fold, non-dose responsive increase was observed
Conclusions:
All criteria for a valid study were met as described in the protocol. The results of the Bacterial Reverse Mutation Assay indicate that, under the conditions of this study, the test substance was concluded equivocal in the presence of Aroclor-induced rat liver S9 with tester strain TA98.
Executive summary:

No contaminant colonies were observed on the sterility plates for the vehicle control, the test article dilutions or the S9 and Sham mixes.

Preliminary Toxicity Assay

The results of the preliminary toxicity assay conducted at dose levels of 6.67, 10.0, 33.3, 66.7, 100, 333, 667, 1000, 3333 and 5000 μg per plate in ethanol. The maximum dose of 5000 μg per plate was achieved using a concentration of 100 mg/mL and a 50.0 μL plating aliquot. Precipitate was observed beginning at 333 or 667 μg per plate. Toxicity was observed beginning at 33.3 to 667 μg per plate.

Mutagenicity Assay

Based upon the results of the preliminary toxicity assay, the dose levels selected for the mutagenicity assay were 2.50, 7.50, 25.0, 75.0, 250 and 750 μg per plate with S9 activation and 0.250, 0.750, 2.50, 7.50, 25.0 and 75.0 μg per plate without S9 activation.

Precipitate was observed at 750 μg per plate in the presence of S9 activation. Toxicity was observed beginning at 25.0 to 750 μg per plate. A 1.5-fold, non-dose responsive increase was observed with tester strain TA98 in the presence of S9 activation. Two replicates at the highest nontoxic dose levels were outside the 95% vehicle control limits and one value and the mean were within 95% vehicle control limits.

Based upon these results, the dose levels selected for the retest of mutagenicity assay were 7.50, 25.0, 75.0, 150, 250, 300, 500 and 750 μg per plate for tester strain TA98 with S9 activation. Precipitate was observed beginning at 300 μg per plate. Toxicity was observed beginning at 500 μg per plate. A 2.0-fold, non-dose responsive increase was observed. Two replicates at the highest nontoxic dose levels were outside the 95% vehicle control limits without a clear dose response. Due to lack of a dose response the conclusion was equivocal.

Based on the study report, the results indicate the test substance is non mutagenic. A negative result was observed in 4 strains of bacteria but an equivocal result was seen in one strain.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (positive)

Additional information

Justification for classification or non-classification

Based on the study report, the results indicate the test substance is non mutagenic - Negative result was observed in 4 strains of bacteria but equivocal result was seen in one strain.